Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

Rule-breaking discovery: Researchers found a pond protist that reassigns all three standard genetic stop codons to amino acids, overturning a long-held view of code universality. Why it matters: The ...

The pond at Oxford University Parks is not much to look at. It is a small, artificial freshwater basin on the edge of campus, ...

A long-standing assumption about evolution is being challenged by new research showing that vastly different species can rely ...

Enduro Genetics, a synthetic biology startup, raised €12 million ($12.4 million) in Series A funding from Supernova Invest, NOON Ventures, and Sandwater. The funding will be used to expand Enduro’s ...

A graph-based computational tool for detecting previously invisible genetic mutations has been developed. Researchers at the University of California, Los Angeles (UCLA; USA) and the University of ...

This article is part of a larger project by The Michigan Daily examining University of Michigan research trends by analyzing academic paper citations. The Daily spoke with Michael Boehnke, Richard G.

Bushwick biotech firm Matter Bio closed a $7 million seed round last week to advance technologies the company says could prevent and treat diseases linked to the aging process, such as cancer. Matter ...

A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully ...